DAVID HAGAN: Open Payments
NPI 1467433557 · GIBSON CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 25 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $387 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $197 |
| Lilly USA, LLC | 5 | $116 |
| MIMEDX Group, Inc. | 1 | $89 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 1 | $49 |
| Echosens North America, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: BREZTRI, JARDIANCE, ZENPEP, TZIELD, AIRSUPRA, Fibroscan, Ozempic, MOUNJARO.
Industry payments across IL — which companies pay providers there.
